PTGS2 and cholangiocarcinoma: Furthermore, in 80 cholangiocarcinoma samples of patients treated with surgery, the overexpression of COX-2 and VEGF-C correlated positively with the clinical TNM stage but not with the differentiation status of tumor cells.